ArticleFrontiers in neurology
Short-duration migraine without aura in children: a retrospective cohort study of attack duration and prognosis.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Migraine without aura (MwoA) is the most common migraine subtype in children and can cause persistent impairment of quality of life. The International Classification of Headache Disorders, 3rd edition (ICHD-3), requires an attack duration of ≥2 h to diagnose pediatric MwoA; however, this threshold is debated, and several studies suggest that a lower limit may be appropriate in children. Methods: In this single-center retrospective study, children with primary headache seen in our neurology clinic from 2018 to 2023 were identified. Baseline demographic and headache characteristics were extracted from records. Patients were grouped by typical attack duration into a short-duration MwoA group (SdMwoA, ≥1 min to <2 h) and an MwoA group. Headache outcomes at 6 months, 12 months and at the last follow-up were collected via clinic visits or structured telephone interviews. Multivariable logistic regression was used to identify factors associated with headache-free status and any improvement at 6 and 12 months. Results: Of the 293 screened children, 192 (97 SdMwoA patients and 95 MwoA patients) met the inclusion criteria; follow-up data were available for 67 (69.1%) and 66 (69.5%) patients, respectively. Compared with the SdMwoA group, the MwoA group more often had a headache history ≥1 month before presentation (61.1% vs. 41.2%, Conclusion: SdMwoA and MwoA have comparable short- to mid-term outcomes. These findings support a more flexible, child-centered interpretation of the ICHD-3 duration criterion in pediatric migraine, indicating that typical migraine phenotypes with attacks less than 2 h warrant consideration of MwoA when alternative diagnoses have been excluded.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.